eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2007
vol. 3
 
Share:
Share:
more
 
 
abstract:

Review paper
Over a decade treating hepatocellular carcinoma percutaneously with radiofrequency thermal ablation. Worldwide experience

Loukas Thanos
,
Sofia Mylona
,
Nikolaos Ptohis
,
Eva Sotiropoulou
,
Anastasia Pomoni
,
Maria Pomoni

Arch Med Sci 2007; 3, 4: 293-304
Online publish date: 2008/01/09
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Hepatocellular carcinoma (HCC) is a very common malignancy. Early diagnosis plays a significant role in the management of patients, affecting survival and prognosis. Surgical resection is the treatment of choice; yet only a small number of patients are surgical candidates at the time of diagnosis. Furthermore, recurrences are very common even after a successful resection. These reasons urged the need to introduce a minimally invasive technique that can be repeated, without the fear of increasing mortality, morbidity, hospitalization and treatment-related cost. In the present article we present our long-standing experience regarding radiofrequency thermal ablation (RFA) treatment of HCC. Indications, clinical results from other investigators and complications are discussed. Additionally there is a description of the technique and the equipment used.
keywords:

radiofrequency ablation, hepatocellular carcinoma, treatment, complications, indications, clinical results

FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe